We are live on ! Find out more
OCRX

Ocera Therapeutics
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

33 hedge funds and large institutions have $14.7M invested in Ocera Therapeutics in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 → 33 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

6% less capital inflows, than outflows

Capital inflows: $1.69M | Capital outflows: $1.8M

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
33
Holders Change
–
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
6
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OCRX Hedge Fund Activity: Q2 2016 in Review

33 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics (OCRX) for Q2 2016, worth a combined $14.7M — down 36% from $22.9M a quarter earlier.

Fund positioning in OCRX was balanced in Q2 2016: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 10 trimmed.

The largest buyer was Deerfield Management, adding an estimated $1.31M. The largest seller was Turner Investments, cutting an estimated $816K.

  • 33 institutional investors held Ocera Therapeutics (OCRX) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $14.7M of Ocera Therapeutics stock for Q2 2016, down 36% quarter-over-quarter.
  • 3 funds opened new Ocera Therapeutics positions in Q2 2016 and 3 closed out, a net change of 0 holders.
  • The largest Ocera Therapeutics buyer in Q2 2016 was Deerfield Management, an estimated $1.31M added.
  • The largest Ocera Therapeutics seller in Q2 2016 was Turner Investments, an estimated $816K sold.

Based on aggregated 13F filings for Q2 2016.